Outcomes of peripheral vasculopathy, including Raynaud’s phenomenon, ended up noticed in postmarketing reports and at the therapeutic dosages of CNS stimulants in all age groups all through the study course of procedure. Indicators and signs commonly improved immediately after dosage reduction